Compare Nutanix Inc (NTNX) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nutanix Inc vs Novartis AG — how do they compare? Nutanix Inc trades at $54 (market cap $14.90B), while Novartis AG trades at $153.88 (market cap $290.25B). The key difference: Novartis AG is far larger — about 19.5× Nutanix Inc's market cap, and Novartis AG pays a 3.17% dividend while Nutanix Inc pays none. Which is the better fit depends on your goals.
| NTNX | NVS | |
|---|---|---|
Market Cap | $14.90B | $290.25B |
Sector | Technology | Health |
52-Week High | $81.12 | $168.62 |
52-Week Low | $34.41 | $113.50 |
Enterprise Value | $14.41B | $330.27B |
Dividend Yield | — | 3.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nutanix Inc
Nutanix, Inc. is a global leader in cloud software and hyperconverged infrastructure (HCI) solutions. The company's platform converges computing, virtualization, and storage into a single, seamless software-defined solution, enabling private, hybrid, and multi-cloud environments. Nutanix helps organizations simplify data center operations, manage their applications across various cloud platforms, and reduce IT complexity, positioning it as a key enabler of modern hybrid cloud strategies.
Read more on NTNX →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
